{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:49:54Z","timestamp":1784083794576,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103446"],"award-info":[{"award-number":["82103446"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273226"],"award-info":[{"award-number":["82273226"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473215"],"award-info":[{"award-number":["82473215"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010097","name":"China Association for Science and Technology","doi-asserted-by":"publisher","award":["2020QNRC001"],"award-info":[{"award-number":["2020QNRC001"]}],"id":[{"id":"10.13039\/100010097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007547","name":"Fourth Military Medical University","doi-asserted-by":"publisher","award":["2021LC2115"],"award-info":[{"award-number":["2021LC2115"]}],"id":[{"id":"10.13039\/501100007547","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shaanxi San-qin Special Support Program Innovation and Entrepreneurship Team"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"DOI":"10.1007\/s00262-025-03996-3","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T13:40:29Z","timestamp":1741441229000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Microbial dysbiosis with tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancer"],"prefix":"10.1007","volume":"74","author":[{"given":"Xiang-xiang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-xin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-geng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-rui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-bo","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"issue":"3","key":"3996_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"3996_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1200\/jco.20.01605","volume":"39","author":"H Borghaei","year":"2021","unstructured":"Borghaei H, Gettinger S, Vokes EE, Chow LQM, Burgio MA, de Castro CJ et al (2021) Five-year outcomes from the randomized, phase iii trials checkmate 017 and 057: nivolumab versus docetaxel in previously treated non-small-cell lung cancer. J Clin Oncol 39(7):723\u2013733. https:\/\/doi.org\/10.1200\/jco.20.01605","journal-title":"J Clin Oncol"},{"issue":"7","key":"3996_CR3","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA et al (2020) The effect of advances in lung-cancer treatment on population mortality. N Engl J Med 383(7):640\u2013649. https:\/\/doi.org\/10.1056\/NEJMoa1916623","journal-title":"N Engl J Med"},{"issue":"1","key":"3996_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jtho.2020.09.022","volume":"16","author":"J Mazieres","year":"2021","unstructured":"Mazieres J, Rittmeyer A, Gadgeel S, Hida T, Gandara DR, Cortinovis DL et al (2021) Atezolizumab versus docetaxel in pretreated patients with nsclc: final results from the randomized phase 2 POPLAR and phase 3 OAK clinical trials. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 16(1):140\u2013150. https:\/\/doi.org\/10.1016\/j.jtho.2020.09.022","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"6","key":"3996_CR5","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1093\/annonc\/mdz109","volume":"30","author":"S Peters","year":"2019","unstructured":"Peters S, Reck M, Smit EF, Mok T, Hellmann MD (2019) How to make the best use of immunotherapy as first-line treatment of advanced\/metastatic non-small-cell lung cancer. Annal Oncol Off J Eur Soc Med Oncol 30(6):884\u2013896. https:\/\/doi.org\/10.1093\/annonc\/mdz109","journal-title":"Annal Oncol Off J Eur Soc Med Oncol"},{"key":"3996_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-022-10074-y","author":"X Wang","year":"2023","unstructured":"Wang X, Qiao Z, Aramini B, Lin D, Li X, Fan J (2023) Potential biomarkers for immunotherapy in non-small-cell lung cancer. Cancer Metastasis Rev. https:\/\/doi.org\/10.1007\/s10555-022-10074-y","journal-title":"Cancer Metastasis Rev"},{"issue":"8","key":"3996_CR7","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/j.jtho.2019.04.007","volume":"14","author":"Y Jin","year":"2019","unstructured":"Jin Y, Dong H, Xia L, Yang Y, Zhu Y, Shen Y et al (2019) The diversity of gut microbiome is associated with favorable responses to anti-programmed death 1 immunotherapy in Chinese patients with NSCLC. J Thorac Oncol Off Publ Int Assoc Study Lung Cancer 14(8):1378\u20131389. https:\/\/doi.org\/10.1016\/j.jtho.2019.04.007","journal-title":"J Thorac Oncol Off Publ Int Assoc Study Lung Cancer"},{"issue":"10","key":"3996_CR8","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1136\/gutjnl-2020-321153","volume":"69","author":"WY Cheng","year":"2020","unstructured":"Cheng WY, Wu CY, Yu J (2020) The role of gut microbiota in cancer treatment: friend or foe? Gut 69(10):1867\u20131876. https:\/\/doi.org\/10.1136\/gutjnl-2020-321153","journal-title":"Gut"},{"issue":"10","key":"3996_CR9","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1158\/2326-6066.Cir-20-0196","volume":"8","author":"T Hakozaki","year":"2020","unstructured":"Hakozaki T, Richard C, Elkrief A, Hosomi Y, Benla\u00effaoui M, Mimpen I et al (2020) The gut microbiome associates with immune checkpoint inhibition outcomes in patients with advanced non-small cell lung cancer. Cancer Immunol Res 8(10):1243\u20131250. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0196","journal-title":"Cancer Immunol Res"},{"issue":"3","key":"3996_CR10","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/ijc.34033","volume":"151","author":"G Martini","year":"2022","unstructured":"Martini G, Ciardiello D, Dallio M, Famiglietti V, Esposito L, Corte CMD et al (2022) Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab. Int J Cancer 151(3):473\u2013480. https:\/\/doi.org\/10.1002\/ijc.34033","journal-title":"Int J Cancer"},{"issue":"1","key":"3996_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12967-020-02231-0","volume":"18","author":"A Botticelli","year":"2020","unstructured":"Botticelli A, Vernocchi P, Marini F, Quagliariello A, Cerbelli B, Reddel S et al (2020) Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment. J Transl Med 18(1):49. https:\/\/doi.org\/10.1186\/s12967-020-02231-0","journal-title":"J Transl Med"},{"issue":"6371","key":"3996_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","volume":"359","author":"V Gopalakrishnan","year":"2018","unstructured":"Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV et al (2018) Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science 359(6371):97\u2013103. https:\/\/doi.org\/10.1126\/science.aan4236","journal-title":"Science"},{"issue":"2","key":"3996_CR13","doi-asserted-by":"publisher","first-page":"156","DOI":"10.5644\/ama2006-124.294","volume":"49","author":"S Dick","year":"2020","unstructured":"Dick S, Turner S (2020) The airway microbiome and childhood asthma - what is the link? Acta Medica Academica 49(2):156\u2013163. https:\/\/doi.org\/10.5644\/ama2006-124.294","journal-title":"Acta Medica Academica"},{"issue":"2","key":"3996_CR14","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02251-22","volume":"11","author":"R Enaud","year":"2023","unstructured":"Enaud R, Lussac-Sorton F, Charpentier E, Velo-Su\u00e1rez L, Guiraud J, Bui S et al (2023) Effects of lumacaftor-ivacaftor on airway microbiota-mycobiota and inflammation in patients with cystic fibrosis appear to be linked to pseudomonas aeruginosa chronic colonization. Microbiol Spectr 11(2):e0225122. https:\/\/doi.org\/10.1128\/spectrum.02251-22","journal-title":"Microbiol Spectr"},{"key":"3996_CR15","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.2147\/idr.S402828","volume":"16","author":"KSM Salama","year":"2023","unstructured":"Salama KSM, Moazen EM, Elsawy SB, Kotb SF, Mohammed EM, Tahoun SA et al (2023) Bacterial species and inflammatory cell variability in respiratory tracts of patients with chronic obstructive pulmonary disease exacerbation: a multicentric study. Infect Drug Resist 16:2107\u20132115. https:\/\/doi.org\/10.2147\/idr.S402828","journal-title":"Infect Drug Resist"},{"issue":"5","key":"3996_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/nrmicro.2017.14","volume":"15","author":"WH Man","year":"2017","unstructured":"Man WH, de Steenhuijsen Piters WA, Bogaert D (2017) The microbiota of the respiratory tract: gatekeeper to respiratory health. Nat Rev Microbiol 15(5):259\u2013270. https:\/\/doi.org\/10.1038\/nrmicro.2017.14","journal-title":"Nat Rev Microbiol"},{"issue":"4","key":"3996_CR17","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1164\/rccm.201711-2180OC","volume":"198","author":"RP Dickson","year":"2018","unstructured":"Dickson RP, Erb-Downward JR, Falkowski NR, Hunter EM, Ashley SL, Huffnagle GB (2018) The lung microbiota of healthy mice are highly variable, cluster by environment, and reflect variation in baseline lung innate immunity. Am J Respir Crit Care Med 198(4):497\u2013508. https:\/\/doi.org\/10.1164\/rccm.201711-2180OC","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"3996_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/s41392-023-01722-y","volume":"9","author":"R Li","year":"2024","unstructured":"Li R, Li J, Zhou X (2024) Lung microbiome: new insights into the pathogenesis of respiratory diseases. Signal Transduct Target Ther 9(1):19. https:\/\/doi.org\/10.1038\/s41392-023-01722-y","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3996_CR19","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1186\/s12931-021-01919-1","volume":"22","author":"HJ Jang","year":"2021","unstructured":"Jang HJ, Choi JY, Kim K, Yong SH, Kim YW, Kim SY et al (2021) Relationship of the lung microbiome with PD-L1 expression and immunotherapy response in lung cancer. Respir Res 22(1):322. https:\/\/doi.org\/10.1186\/s12931-021-01919-1","journal-title":"Respir Res"},{"issue":"3","key":"3996_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41591-019-0377-7","volume":"25","author":"BA Helmink","year":"2019","unstructured":"Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA (2019) The microbiome, cancer, and cancer therapy. Nat Med 25(3):377\u2013388. https:\/\/doi.org\/10.1038\/s41591-019-0377-7","journal-title":"Nat Med"},{"issue":"1","key":"3996_CR21","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","volume":"11","author":"LF Campesato","year":"2020","unstructured":"Campesato LF, Budhu S, Tchaicha J, Weng CH, Gigoux M, Cohen IJ et al (2020) Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine. Nat Commun 11(1):4011. https:\/\/doi.org\/10.1038\/s41467-020-17750-z","journal-title":"Nat Commun"},{"issue":"5","key":"3996_CR22","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1158\/1078-0432.Ccr-18-2882","volume":"25","author":"BW Labadie","year":"2019","unstructured":"Labadie BW, Bao R, Luke JJ (2019) Reimagining IDO pathway inhibition in cancer immunotherapy via downstream focus on the tryptophan-kynurenine-aryl hydrocarbon axis. Clin Cancer Res Off J Am Assoc Cancer Res 25(5):1462\u20131471. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-18-2882","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"9","key":"3996_CR23","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1016\/j.cell.2023.03.011","volume":"186","author":"MJ Bender","year":"2023","unstructured":"Bender MJ, McPherson AC, Phelps CM, Pandey SP, Laughlin CR, Shapira JH et al (2023) Dietary tryptophan metabolite released by intratumoral lactobacillus reuteri facilitates immune checkpoint inhibitor treatment. Cell 186(9):1846\u201362.e26. https:\/\/doi.org\/10.1016\/j.cell.2023.03.011","journal-title":"Cell"},{"issue":"7950","key":"3996_CR24","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","volume":"615","author":"J Tintelnot","year":"2023","unstructured":"Tintelnot J, Xu Y, Lesker TR, Sch\u00f6nlein M, Konczalla L, Giannou AD et al (2023) Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer. Nature 615(7950):168\u2013174. https:\/\/doi.org\/10.1038\/s41586-023-05728-y","journal-title":"Nature"},{"key":"3996_CR25","doi-asserted-by":"publisher","unstructured":"PD-1 inhibitors raise survival in NSCLC. Cancer Discov 2014;4(1):6 https:\/\/doi.org\/10.1158\/2159-8290.Cd-nb2013-164","DOI":"10.1158\/2159-8290.Cd-nb2013-164"},{"issue":"Pt 3","key":"3996_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.semcancer.2022.07.006","volume":"86","author":"T Goto","year":"2022","unstructured":"Goto T (2022) Microbiota and lung cancer. Semin Cancer Biol 86(Pt 3):1\u201310. https:\/\/doi.org\/10.1016\/j.semcancer.2022.07.006","journal-title":"Semin Cancer Biol"},{"key":"3996_CR27","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.lungcan.2016.10.016","volume":"102","author":"SH Lee","year":"2016","unstructured":"Lee SH, Sung JY, Yong D, Chun J, Kim SY, Song JH et al (2016) Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions. Lung Cancer 102:89\u201395. https:\/\/doi.org\/10.1016\/j.lungcan.2016.10.016","journal-title":"Lung Cancer"},{"issue":"2","key":"3996_CR28","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1158\/2159-8290.Cd-20-0263","volume":"11","author":"JJ Tsay","year":"2021","unstructured":"Tsay JJ, Wu BG, Sulaiman I, Gershner K, Schluger R, Li Y et al (2021) Lower airway dysbiosis affects lung cancer progression. Cancer Discov 11(2):293\u2013307. https:\/\/doi.org\/10.1158\/2159-8290.Cd-20-0263","journal-title":"Cancer Discov"},{"key":"3996_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02554-x","author":"JE Joo","year":"2024","unstructured":"Joo JE, Chu YL, Georgeson P, Walker R, Mahmood K, Clendenning M et al (2024) Intratumoral presence of the genotoxic gut bacteria pks(+) E. coli, enterotoxigenic bacteroides fragilis, and fusobacterium nucleatum and their association with clinicopathological and molecular features of colorectal cancer. British J Cancer. https:\/\/doi.org\/10.1038\/s41416-023-02554-x","journal-title":"British J Cancer"},{"issue":"10","key":"3996_CR30","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1158\/2326-6066.Cir-20-0051","volume":"8","author":"Y Tomita","year":"2020","unstructured":"Tomita Y, Ikeda T, Sakata S, Saruwatari K, Sato R, Iyama S et al (2020) Association of probiotic clostridium butyricum therapy with survival and response to immune checkpoint blockade in patients with lung cancer. Cancer Immunol Res 8(10):1236\u20131242. https:\/\/doi.org\/10.1158\/2326-6066.Cir-20-0051","journal-title":"Cancer Immunol Res"},{"key":"3996_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073628","author":"DE Kiousi","year":"2022","unstructured":"Kiousi DE, Kouroutzidou AZ, Neanidis K, Matthaios D, Pappa A, Galanis A (2022) Evaluating the role of probiotics in the prevention and management of age-related diseases. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms23073628","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3996_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/s41568-019-0222-9","volume":"20","author":"M Fane","year":"2020","unstructured":"Fane M, Weeraratna AT (2020) How the ageing microenvironment influences tumour progression. Nat Rev Cancer 20(2):89\u2013106. https:\/\/doi.org\/10.1038\/s41568-019-0222-9","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"3996_CR33","doi-asserted-by":"publisher","first-page":"7046","DOI":"10.1080\/21655979.2021.1972077","volume":"12","author":"T He","year":"2021","unstructured":"He T, Cheng X, Xing C (2021) The gut microbial diversity of colon cancer patients and the clinical significance. Bioengineered 12(1):7046\u20137060. https:\/\/doi.org\/10.1080\/21655979.2021.1972077","journal-title":"Bioengineered"},{"issue":"1","key":"3996_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13027-022-00425-3","volume":"17","author":"NM Premachandra","year":"2022","unstructured":"Premachandra NM, Jayaweera J (2022) Chlamydia pneumoniae infections and development of lung cancer: systematic review. Infect Agents Cancer 17(1):11. https:\/\/doi.org\/10.1186\/s13027-022-00425-3","journal-title":"Infect Agents Cancer"},{"issue":"16","key":"3996_CR35","doi-asserted-by":"publisher","first-page":"5039","DOI":"10.1128\/aem.01235-16","volume":"82","author":"C Urbaniak","year":"2016","unstructured":"Urbaniak C, Gloor GB, Brackstone M, Scott L, Tangney M, Reid G (2016) The microbiota of breast tissue and its association with breast cancer. Appl Environ Microbiol 82(16):5039\u20135048. https:\/\/doi.org\/10.1128\/aem.01235-16","journal-title":"Appl Environ Microbiol"},{"issue":"8","key":"3996_CR36","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/em.21878","volume":"55","author":"HD Hosgood 3rd","year":"2014","unstructured":"Hosgood HD 3rd, Sapkota AR, Rothman N, Rohan T, Hu W, Xu J et al (2014) The potential role of lung microbiota in lung cancer attributed to household coal burning exposures. Environ Mol Mutagen 55(8):643\u2013651. https:\/\/doi.org\/10.1002\/em.21878","journal-title":"Environ Mol Mutagen"},{"issue":"4","key":"3996_CR37","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/ijc.31098","volume":"142","author":"HX Liu","year":"2018","unstructured":"Liu HX, Tao LL, Zhang J, Zhu YG, Zheng Y, Liu D et al (2018) Difference of lower airway microbiome in bilateral protected specimen brush between lung cancer patients with unilateral lobar masses and control subjects. Int J Cancer 142(4):769\u2013778. https:\/\/doi.org\/10.1002\/ijc.31098","journal-title":"Int J Cancer"},{"issue":"10","key":"3996_CR38","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1158\/2326-6066.Cir-19-1014","volume":"8","author":"Z Peng","year":"2020","unstructured":"Peng Z, Cheng S, Kou Y, Wang Z, Jin R, Hu H et al (2020) The gut microbiome is associated with clinical response to anti-pd-1\/pd-l1 immunotherapy in gastrointestinal cancer. Cancer Immunol Res 8(10):1251\u20131261. https:\/\/doi.org\/10.1158\/2326-6066.Cir-19-1014","journal-title":"Cancer Immunol Res"},{"issue":"8","key":"3996_CR39","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1111\/cas.14979","volume":"112","author":"C Zhang","year":"2021","unstructured":"Zhang C, Wang J, Sun Z, Cao Y, Mu Z, Ji X (2021) Commensal microbiota contributes to predicting the response to immune checkpoint inhibitors in non-small-cell lung cancer patients. Cancer Sci 112(8):3005\u20133017. https:\/\/doi.org\/10.1111\/cas.14979","journal-title":"Cancer Sci"},{"issue":"1","key":"3996_CR40","doi-asserted-by":"publisher","first-page":"2204746","DOI":"10.1080\/2162402x.2023.2204746","volume":"12","author":"D Dora","year":"2023","unstructured":"Dora D, Ligeti B, Kovacs T, Revisnyei P, Galffy G, Dulka E et al (2023) Non-small cell lung cancer patients treated with Anti-PD1 immunotherapy show distinct microbial signatures and metabolic pathways according to progression-free survival and PD-L1 status. Oncoimmunology 12(1):2204746. https:\/\/doi.org\/10.1080\/2162402x.2023.2204746","journal-title":"Oncoimmunology"},{"key":"3996_CR41","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fimmu.2019.00168","volume":"10","author":"P Bonaventura","year":"2019","unstructured":"Bonaventura P, Shekarian T, Alcazer V, Valladeau-Guilemond J, Valsesia-Wittmann S, Amigorena S et al (2019) Cold tumors: a therapeutic challenge for immunotherapy. Front Immunol 10:168. https:\/\/doi.org\/10.3389\/fimmu.2019.00168","journal-title":"Front Immunol"},{"key":"3996_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s44280-023-00020-0","author":"J Zhu","year":"2023","unstructured":"Zhu J, Chen Y, Imre K, Arslan-Acaroz D, Istanbullugil FR, Fang Y et al (2023) Mechanisms of probiotic bacillus against enteric bacterial infections. One Health Adv. https:\/\/doi.org\/10.1186\/s44280-023-00020-0","journal-title":"One Health Adv"},{"issue":"7742","key":"3996_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s41586-019-0884-1","volume":"566","author":"N Morita","year":"2019","unstructured":"Morita N, Umemoto E, Fujita S, Hayashi A, Kikuta J, Kimura I et al (2019) GPR31-dependent dendrite protrusion of intestinal CX3CR1(+) cells by bacterial metabolites. Nature 566(7742):110\u2013114. https:\/\/doi.org\/10.1038\/s41586-019-0884-1","journal-title":"Nature"},{"key":"3996_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.107973","volume":"231","author":"G Roviello","year":"2022","unstructured":"Roviello G, Iannone LF, Bersanelli M, Mini E, Catalano M (2022) The gut microbiome and efficacy of cancer immunotherapy. Pharmacol Ther 231:107973. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107973","journal-title":"Pharmacol Ther"},{"issue":"2","key":"3996_CR45","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/iub.1969","volume":"71","author":"R Mendez","year":"2019","unstructured":"Mendez R, Banerjee S, Bhattacharya SK, Banerjee S (2019) Lung inflammation and disease: a perspective on microbial homeostasis and metabolism. IUBMB Life 71(2):152\u2013165. https:\/\/doi.org\/10.1002\/iub.1969","journal-title":"IUBMB Life"},{"issue":"9","key":"3996_CR46","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.cell.2024.03.021","volume":"187","author":"TW Battaglia","year":"2024","unstructured":"Battaglia TW, Mimpen IL, Traets JJH, van Hoeck A, Zeverijn LJ, Geurts BS et al (2024) A pan-cancer analysis of the microbiome in metastatic cancer. Cell 187(9):2324\u201335.e19. https:\/\/doi.org\/10.1016\/j.cell.2024.03.021","journal-title":"Cell"},{"issue":"1","key":"3996_CR47","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/s13059-016-1021-1","volume":"17","author":"G Yu","year":"2016","unstructured":"Yu G, Gail MH, Consonni D, Carugno M, Humphrys M, Pesatori AC et al (2016) Characterizing human lung tissue microbiota and its relationship to epidemiological and clinical features. Genome Biol 17(1):163. https:\/\/doi.org\/10.1186\/s13059-016-1021-1","journal-title":"Genome Biol"},{"issue":"5","key":"3996_CR48","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.12.040","volume":"176","author":"C Jin","year":"2019","unstructured":"Jin C, Lagoudas GK, Zhao C, Bullman S, Bhutkar A, Hu B et al (2019) Commensal microbiota promote lung cancer development via \u03b3\u03b4 t cells. Cell 176(5):998-1013.e16. https:\/\/doi.org\/10.1016\/j.cell.2018.12.040","journal-title":"Cell"},{"issue":"14","key":"3996_CR49","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1111\/1759-7714.15303","volume":"15","author":"S Ren","year":"2024","unstructured":"Ren S, Feng L, Liu H, Mao Y, Yu Z (2024) Gut microbiome affects the response to immunotherapy in non-small cell lung cancer. Thorac cancer 15(14):1149\u20131163. https:\/\/doi.org\/10.1111\/1759-7714.15303","journal-title":"Thorac cancer"},{"issue":"1","key":"3996_CR50","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00281-018-0702-0","volume":"41","author":"AJ Muller","year":"2019","unstructured":"Muller AJ, Manfredi MG, Zakharia Y, Prendergast GC (2019) Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond. Seminar Immunopathol 41(1):41\u201348. https:\/\/doi.org\/10.1007\/s00281-018-0702-0","journal-title":"Seminar Immunopathol"},{"issue":"2","key":"3996_CR51","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/2326-6066.Cir-14-0137","volume":"3","author":"I Th\u00e9ate","year":"2015","unstructured":"Th\u00e9ate I, van Baren N, Pilotte L, Moulin P, Larrieu P, Renauld JC et al (2015) Extensive profiling of the expression of the indoleamine 2,3-dioxygenase 1 protein in normal and tumoral human tissues. Cancer Immunol Res 3(2):161\u2013172. https:\/\/doi.org\/10.1158\/2326-6066.Cir-14-0137","journal-title":"Cancer Immunol Res"},{"issue":"7","key":"3996_CR52","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.cell.2024.02.022","volume":"187","author":"D Jia","year":"2024","unstructured":"Jia D, Wang Q, Qi Y, Jiang Y, He J, Lin Y et al (2024) Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer. Cell 187(7):1651\u201365.e21. https:\/\/doi.org\/10.1016\/j.cell.2024.02.022","journal-title":"Cell"},{"issue":"12","key":"3996_CR53","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","volume":"72","author":"W Fong","year":"2023","unstructured":"Fong W, Li Q, Ji F, Liang W, Lau HCH, Kang X et al (2023) Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis. Gut 72(12):2272\u20132285. https:\/\/doi.org\/10.1136\/gutjnl-2023-329543","journal-title":"Gut"},{"key":"3996_CR54","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20221682","author":"AA Badawy","year":"2022","unstructured":"Badawy AA (2022) Tryptophan metabolism and disposition in cancer biology and immunotherapy. Biosci Rep. https:\/\/doi.org\/10.1042\/bsr20221682"},{"issue":"1","key":"3996_CR55","doi-asserted-by":"publisher","first-page":"5753","DOI":"10.1038\/s41467-023-41536-8","volume":"14","author":"G Renga","year":"2023","unstructured":"Renga G, D\u2019Onofrio F, Pariano M, Galarini R, Barola C, Stincardini C et al (2023) Bridging of host-microbiota tryptophan partitioning by the serotonin pathway in fungal pneumonia. Nat Commun 14(1):5753. https:\/\/doi.org\/10.1038\/s41467-023-41536-8","journal-title":"Nat Commun"},{"issue":"8","key":"3996_CR56","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/s41575-021-00430-8","volume":"18","author":"B Stockinger","year":"2021","unstructured":"Stockinger B, Shah K, Wincent E (2021) AHR in the intestinal microenvironment: safeguarding barrier function. Nat Rev Gastroenterol Hepatol 18(8):559\u2013570. https:\/\/doi.org\/10.1038\/s41575-021-00430-8","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-03996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-025-03996-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-025-03996-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T09:40:19Z","timestamp":1743068419000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-025-03996-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["3996"],"URL":"https:\/\/doi.org\/10.1007\/s00262-025-03996-3","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20221682","asserted-by":"subject"}]},"ISSN":["1432-0851"],"issn-type":[{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"29 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"140"}}